Jason Vedadi already ran the playbook once. He built Harvest Health & Recreation into one of the largest multistate cannabis operators in the country, then sold it to Trulieve Cannabis Corp. in a $2.1 billion deal that still ranks among the biggest transactions the industry has ever produced. Now, running privately held Story Cannabis out of Phoenix, he's doing something that sounds almost contrarian for a founder with that kind of exit under his belt: staying small on purpose.
Story Cannabis employs 800 people across five states - Arizona, Maryland, Ohio, Georgia and Louisiana - with adult-use and medical licenses split between them, including two markets that remain medical-only. That's a far narrower footprint than Harvest ever carried, and it's deliberate. Operators everywhere have gotten sharper about back-office fundamentals over the past several years, from inventory shrinkage controls to wholesale menu discipline, and the operational bar for turning a profit has risen accordingly. Even the software layer underneath a dispensary matters more than it used to; a well-configured cannabis POS for Oregon dispensaries or any regulated market now has to handle compliant packaging rules, tax reporting and seed-to-sale tracking without friction, because regulators aren't forgiving errors the way they might have during the industry's earlier, looser years. cannabis POS for Oregon dispensaries
Picking Markets Instead of Collecting Them
Vedadi's read on the current cycle is straightforward: footprint alone no longer wins. "In 2017, 2018, you were more rewarded on footprint because markets were more immature," he said. Today, license caps, local ownership rules and wholesale price compression separate profitable states from ones that quietly bleed capital. Maryland's four-store ownership limit, for instance, boxes out consolidation by design. Arizona, where Story has operated since 2011, is the exception - steady, familiar, and the one market where the company will keep acquiring rather than waiting for new license rounds.
Georgia is the standout opportunity right now. The state recently moved off its restrictive low-THC oil program, lifted the 5% THC cap, and broadened qualifying conditions - effectively converting a niche medical program into something closer to a traditional one. With 11 million residents and a limited operator pool, that's the kind of structural opening Vedadi says he's chasing in Texas, Virginia and North Carolina as well, preferring competitive license applications over buying an existing operator's seat at the table.
Rescheduling, Consolidation, and What Comes Next
Medical cannabis is now a Schedule 3 drug, and Story has applied for DEA registration on its MMJ permits in Arizona, Georgia, Maryland and Ohio. The bigger question - whether the entire plant, adult-use included, gets rescheduled - remains unresolved, and Vedadi says the industry is sitting in limbo waiting for that answer. His expectation is that full rescheduling triggers a wave of consolidation, larger public operators moving first, smaller ones getting absorbed after. It could also open the door for uplisting to the New York Stock Exchange, though Story intends to stay private for now.
The catch, as Vedadi points out, is that license caps will determine which states even allow that kind of consolidation to happen. In markets like Maryland, a founder who wants to build and eventually sell may find there's simply no buyer permitted to acquire past a certain store count. That's a structural problem, not a market one - and it's a reminder that in cannabis retail, regulatory architecture still shapes exit outcomes as much as consumer demand does.
